Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Applying to UPMC Pinnacle Cancer Center/Community Osteopathic Campus · Harrisburg, Pennsylvania
Answer a few short questions to share with the research team.